Loading viewer...
investor_presentation
Format: PDF investor_presentation
Pasithea Therapeutics is a clinical-stage biotech company developing novel therapeutics, including PAS-004, for advanced cancer and other indications. The presentation outlines the company's leadership team, clinical development programs, and strategic objectives to advance its product pipeline.
investor_presentation
88 Pages
Silicon Laboratories Inc.
Teva Pharmaceutical Industries Investor Presentation — November 2018
investor_presentationinvestor_presentation
38 Pages
Teva Pharmaceutical Industries